Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T20:31:11.542Z.
Calculation as of: 2026-10-06T20:31:11.542Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$44.71M
Free Cash Flow Yield
9.49%
TTM Avg
5.71%
3Y Avg
3.18%
5Y Avg
3.18%
Market Cap
$44.72M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.72M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.26M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.95M
Free Cash Flow Yield
N/A
TTM Avg
8.38%
3Y Avg
7.29%
5Y Avg
5.95%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $44.02M | N/A | N/A | N/A | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 9.49% | 5.71% | 3.18% | 3.18% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $42.99M | N/A | N/A | N/A | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | N/A | N/A | N/A | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $45.73M | N/A | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | N/A | 8.38% | 7.29% | 5.95% |
| Precipio, Inc. (PRPO)vs › | $41.83M | 1.89% | 1.42% | 1.97% | 1.97% |
FCF Yield
N/A
Earnings Yield
11.46%
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
